‘Seed to Sale Certified’ quality promise of Aphria Inc (TSE:APH) was introduced following company’s long-standing commitment to the grow and production of safe and clean medicinal cannabis.
However, Vic Neufeld, who is the CEO of the company, mentioned that this quality promise plan is not something new that they are implementing. Right from the start, their focus has remained on grade quality assurance and management plan. In the upcoming period too, they will continue to focused on being transparent on their processes that permit them to bring the change in growing best quality medicinal cannabis.
The Seed to Sale will focus on all the different aspects, right from the way the seeds are characterized, to tightly regulated grow cycle, to stringent product testing and established supply chain. As mentioned earlier Aphria will make only those products available for sale that meet strict standards for reliability, safety and excellence.
The quality promise reinforces Aphria’s contemporary quality management program, which encompasses over 500 steps that beat industry regulations set on Licensed Producers by Health Canada. This new quality promise can be introduced onto firm’s product packaging in the upcoming weeks to offer an identifiable and trusted symbol to patients that offerings are tested, clean and safe.
The 509 steps that establish Aphria’s quality management approach are categorized into five prime sections, each of which is critically dynamic to ensuring that consumers get best quality products every time. These steps encompass advanced facility, tightly-controlled grow plans, quality manufacturing and mechanisms, recognized supply chain and standard processes and training
Aphria announced that as part of its commitment to quality, it continues to encourage stringent product-testing across the medical marijuana sector as a necessary guideline to safeguard the safety and health of company’s customers.